RIPK3 and chronic kidney disease: There is a body of evidence indicating that a lack of RIPK3 and MLKL expression can reduce kidney damage due to IRI, and the necroinflammation driven by RIPK3/MLKL-dependent necroptosis may lead to the progression of IRI to CKD [29].